Mirae Asset Global ETFs Holdings
RCEL icon

Mirae Asset Global ETFs Holdings’s Avita Medical RCEL Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio RCEL Stock Details RCEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$22.3K Buy
6,015
+176
+3% +$739 ﹤0.01% 3035
2025
Q4 		$20.1K Buy
5,839
+176
+3% +$702 ﹤0.01% 3049
2025
Q3 		$28.9K Sell
5,663
-9,394
-62% -$49K ﹤0.01% 3025
2025
Q2 		$79.7K Sell
15,057
-157
-1% -$1.14K ﹤0.01% 2716
2025
Q1 		$124K Buy
15,214
+624
+4% +$5.83K ﹤0.01% 2533
2024
Q4 		$187K Buy
14,590
+608
+4% +$7.17K ﹤0.01% 2415
2024
Q3 		$150K Buy
13,982
+966
+7% +$9.07K ﹤0.01% 2515
2024
Q2 		$103K Buy
+13,016
New +$124K ﹤0.01% 2549

Other funds holding RCEL

O
OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
DSCM
Divisadero Street Capital Management Miami, Florida $2.14B AUM 134.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return